Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

53.88
Delayed Data
As of Feb 24
 +0.30 / +0.56%
Today’s Change
39.35
Today|||52-Week Range
56.50
+0.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$26.5B

Company Description

Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
100 Campus Drive
Florham Park New Jersey 07932
P:(973) 822-7000
Investor Relations:
(973) 822-7088

Employees

Shareholders

Mutual fund holders48.09%
Other institutional47.32%
Individual stakeholders25.95%

Top Executives

Juan Ramón AlaixPresident, Chief Executive Officer & Director
Kristin C. PeckExecutive Vice President & President-US Operations
Glenn DavidChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Andrew FentonExecutive VP & Chief Information Officer